MedPath
FDA Approval

Neuraceq

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 25, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Florbetaben F-18(135 mCi in 1 mL)

Manufacturing Establishments6

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

PharmaLogic Salt Lake City, LLC

Life Molecular Imaging, Ltd

119319723

PharmaLogic Colorado, LLC

Life Molecular Imaging, Ltd

117608150

SOFIE Co. dba SOFIE

Life Molecular Imaging, Ltd

008017970

Jubilant DraxImage Inc. dba Jubilant Radiopharma

Life Molecular Imaging, Ltd

080871701

PharmaLogic Cincinnati, LLC

Life Molecular Imaging, Ltd

118408248

N-Molecular, Inc. dba SOFIE

Life Molecular Imaging, Ltd

079932600

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neuraceq

Product Details

NDC Product Code
54828-001
Application Number
NDA204677
Marketing Category
NDA (C73594)
Route of Administration
INTRAVENOUS
Effective Date
June 13, 2022
Code: TLA7312TOIClass: ACTIBQuantity: 135 mCi in 1 mL
ALCOHOLInactive
Code: 3K9958V90MClass: IACTQuantity: 118 mg in 1 mL
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQClass: IACTQuantity: 200 mg in 1 mL
SODIUM ASCORBATEInactive
Code: S033EH8359Class: IACTQuantity: 28.8 mg in 1 mL
ASCORBIC ACIDInactive
Code: PQ6CK8PD0RClass: IACTQuantity: 4.4 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACTQuantity: 677.5 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath